durvalumab,tremelimumab
astrazeneca,pfizer
['poseidon', 'lung', 'astrazeneca']
late-breaking data at #esmo22: we presented long-term os data, as well as post-hoc exploratory analyses in patients with difficult-to-treat mutations, from our poseidon phase iii trial for first-line treatment of metastatic non-small cell #lungcancer. 
The official Twitter feed for AstraZeneca US. For more info visit http://t.co/5VlUaVGyiC.